FLGT EBITDA
Fulgent Genetics Inc · EBITDA
FLGT EBITDA
Latest reported-$65.02Mperiod ending
FLGT TTM EBITDA (-$4.44M → -$65.02M)
TTM EBITDA
High-resolution chart · PNG
FLGT ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| -65,021,000 | |
| -58,514,000 | |
| -44,343,000 | |
| -22,958,000 | |
| -35,479,000 | |
| -25,067,000 | |
| -26,787,000 | |
| -49,498,000 | |
| -23,551,000 | |
| -26,903,000 | |
| -33,563,000 | |
| -35,985,000 | |
| -39,057,000 | |
| -6,634,000 | |
| 214,209,000 | |
| 395,773,000 | |
| 548,438,000 | |
| 630,057,000 | |
| 692,228,000 | |
| 764,471,000 | |
| 665,774,000 | |
| 563,309,000 | |
| 293,120,000 | |
| 66,238,000 | |
| 4,005,000 | |
| 1,622,000 | |
| 1,679,000 | |
| 1,039,000 | |
| -1,272,000 | |
| -2,517,000 | |
| -2,907,000 | |
| -4,013,000 | |
| -4,757,000 | |
| -4,063,000 | |
| -1,754,000 | |
| 1,521,000 | |
| 2,172,000 | |
| 3,135,000 | |
| 2,088,000 | |
| -6,744,000 | |
| -5,001,000 | |
| -5,349,000 | |
| -4,438,000 |